QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2083401
Abstract: Abstract Objective To examine whether QT interval shortening is an overlooked adverse event as compared to QT prolongation through a review of preclinical, clinical and post-marketing adverse event data available to the regulator for centrally… read more here.
Keywords: proarrhythmic safety; active substances; shortening proarrhythmic; adverse event ... See more keywords